In a world where rare diseases often linger under the radar, Eosinophilic Granulomatosis with Polyangiitis (EGPA) is finally getting its moment in the spotlight. Once considered obscure, this rare autoimmune condition—previously known as Churg-Strauss Syndrome—is now driving significant activity in the global pharmaceutical and biotechnology industries....